These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18570979)

  • 1. Pure or mixed-type invasive lobular carcinoma?
    Bulut N; Dede DS; Sari E; Altundag K
    Hum Pathol; 2008 Jul; 39(7):1121; author reply 1121. PubMed ID: 18570979
    [No Abstract]   [Full Text] [Related]  

  • 2. Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma.
    Sentani K; Tashiro T; Oue N; Yasui W
    APMIS; 2007 Dec; 115(12):1422-5. PubMed ID: 18184414
    [No Abstract]   [Full Text] [Related]  

  • 3. Lobular carcinoma of the breast with extracellular mucin: new variant of mucin-producing carcinomas?
    Rosa M; Mohammadi A; Masood S
    Pathol Int; 2009 Jun; 59(6):405-9. PubMed ID: 19490472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microinvasive (T1mic) lobular carcinoma of the breast: clinicopathologic profile of 16 cases.
    Ross DS; Hoda SA
    Am J Surg Pathol; 2011 May; 35(5):750-6. PubMed ID: 21415700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.
    Webster LR; Lee SF; Ringland C; Morey AL; Hanby AM; Morgan G; Byth K; Mote PA; Provan PJ; Ellis IO; Green AR; Lamoury G; Ravdin P; Clarke CL; Ward RL; Balleine RL; Hawkins NJ
    Clin Cancer Res; 2008 Oct; 14(20):6625-33. PubMed ID: 18927304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic and prognostic evaluation of invasive breast carcinoma molecular subtypes and GATA3 expression.
    Demir H; Turna H; Can G; Ilvan S
    J BUON; 2010; 15(4):774-82. PubMed ID: 21229645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are bilateral breast cancers different from breast cancers coexisting with ovarian cancer? An immunohistochemical analysis aimed at intrinsic tumor phenotype.
    Senkus E; Szade J; Pieczyńska B; Żaczek A; Brożek I; Radecka B; Kowalczyk A; Wełnicka-Jaśkiewicz M; Jassem J
    Breast; 2013 Aug; 22(4):425-30. PubMed ID: 23642527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].
    Mchedlishvili MIu; Gabunia UA; Makharoblidze ER; Burnadze KT; Piradashvili DZ
    Georgian Med News; 2005 Feb; (119):65-7. PubMed ID: 15834186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?
    Goldstein NS
    Am J Clin Pathol; 2002 Sep; 118(3):425-34. PubMed ID: 12219785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of clinicopathologic characteristics and prognosis of triple-negative with Her-2-overexpressing breast cancer].
    Wang YJ; Wang N; Wang B; Qin WX; Xue CY
    Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):346-50. PubMed ID: 19799082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-negative breast cancers: unique clinical presentations and outcomes.
    Billar JA; Dueck AC; Stucky CC; Gray RJ; Wasif N; Northfelt DW; McCullough AE; Pockaj BA
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():384-90. PubMed ID: 20853062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?
    Fadare O; Wang SA; Hileeto D
    Hum Pathol; 2008 Mar; 39(3):331-6. PubMed ID: 18261623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological definition of triple negative breast cancer.
    Viale G; Bottiglieri L
    Eur J Cancer; 2009 Sep; 45 Suppl 1():5-10. PubMed ID: 19775600
    [No Abstract]   [Full Text] [Related]  

  • 15. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
    Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
    Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma.
    Wahed A; Connelly J; Reese T
    Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers.
    Sung H; Garcia-Closas M; Chang-Claude J; Blows FM; Ali HR; Figueroa J; Nevanlinna H; Fagerholm R; Heikkilä P; Blomqvist C; Giles GG; Milne RL; Southey MC; McLean C; Mannermaa A; Kosma VM; Kataja V; Sironen R; Couch FJ; Olson JE; Hallberg E; Olswold C; Cox A; Cross SS; Kraft P; Tamimi RM; Eliassen AH; Schmidt MK; Bolla MK; Wang Q; Easton D; Howat WJ; Coulson P; Pharoah PD; Sherman ME; Yang XR
    Br J Cancer; 2016 Feb; 114(3):298-304. PubMed ID: 26679376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biopathological profile of multiple synchronous homolateral and bilateral breast cancers.
    Cavaliere A; Bellezza G; Scheibel M; Vitali R; Sidoni A
    Pathol Res Pract; 2004; 200(1):9-12. PubMed ID: 15157045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
    Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
    Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual triple-negative breast carcinoma.
    Shousha S; Peston D; Gojis O; Palmieri C
    Histopathology; 2009 Sep; 55(3):364-6. PubMed ID: 19723156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.